CINA-VCF vs CINA-iPE

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 75/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

CINA-VCF

by Avicenna.AI

CINA-iPE

by Avicenna.AI

AI Verdict

These tools are highly comparable in their underlying technology, vendor, and general approach to AI-powered triage in radiology. However, they address distinct clinical needs: CINA-VCF focuses on detecting vertebral compression fractures, while CINA-iPE is designed for identifying incidental pulmonary embolisms. Therefore, the choice between them depends entirely on the specific medical condition requiring AI-assisted detection and prioritization.

Choose CINA-VCF if…

Choose CINA-VCF if your radiology department frequently performs chest and/or abdomen CT scans on patients aged 50 and over and you aim to proactively identify unsuspected vertebral compression fractures. This tool is ideal for improving bone health screening workflows by automatically triaging and notifying radiologists of these incidental findings, leading to earlier intervention and better patient outcomes.

View CINA-VCF →

Choose CINA-iPE if…

Choose CINA-iPE if your facility seeks to enhance the detection of potentially life-threatening incidental pulmonary embolisms across various CT scan types, including chest, abdomen-pelvis, and whole-body. This AI-powered solution is best suited for emergency medicine and radiology departments needing rapid triage and prioritization of critical cases to enable timely treatment and prevent missed diagnoses.

View CINA-iPE →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	CINA-VCF	CINA-iPE
Pricing	Contact for pricing	Subscription
Deployment	Cloud-based, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker)	Cloud-based, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker).
FDA Status	1 AI-estimated	Yes AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Tie

Both CINA-VCF and CINA-iPE are designed for seamless integration into existing radiology workflows, including PACS and RIS. Both tools also boast rapid processing times of 10-60 seconds, indicating similar operational efficiency and user experience within a clinical setting.

Clinical Value

CINA-VCF

While both tools are FDA-cleared and aim to improve patient outcomes by detecting incidental findings, CINA-VCF (Tool A) demonstrates slightly higher reported performance metrics. CINA-VCF has a reported sensitivity of 95.2% and specificity of 92.9%, compared to CINA-iPE (Tool B) with a sensitivity of 87.8-91.1% and specificity of 91.8-92%. These specific metrics suggest a marginally stronger clinical performance for CINA-VCF.

Pricing & Value

Tie

Both tools are offered on a subscription basis, with pricing dependent on factors like the number of installations, users, or analyses. Neither product provides transparent pricing details in the provided information, making it impossible to distinguish which offers better value without direct consultation with the vendor.

Enterprise Readiness

Tie

As products from the same company, Avicenna.AI, both CINA-VCF and CINA-iPE exhibit strong enterprise readiness. They are both FDA-cleared, HIPAA compliant, and offer flexible deployment options including cloud-based, local dedicated hardware, or local virtualization, making them suitable for diverse healthcare IT infrastructures.

Innovation

Tie

Both tools represent significant innovation by leveraging AI for the opportunistic detection and triage of critical incidental findings on CT scans. While they address different clinical conditions (vertebral compression fractures vs. pulmonary embolisms), their core innovative approach of using AI to enhance diagnostic workflows and prevent missed diagnoses is fundamentally similar.

Support & Docs

Tie

The parent company, Avicenna.AI, emphasizes a strong commitment to regulatory compliance and quality management, including adherence to standards like ISO 13485 and IEC 62366-1 (Usability engineering). The company also provides clinical publications and 'Instructions for Use' for its products. Given they are from the same vendor, it's reasonable to assume a consistent level of support and documentation for both tools.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	CINA-VCF	CINA-iPE
Name	CINA-VCF	CINA-iPE
Company	Avicenna.AI	Avicenna.AI
Description	FDA-cleared AI-powered triage and notification software designed to detect unsuspected vertebral compression fractures on chest and/or abdomen CT scans, improving workflow and patient outcomes in radiology.	FDA-cleared AI-powered triage tool from Avicenna.AI that detects unsuspected pulmonary embolisms on CT scans performed for other health conditions, enabling radiologists to initiate early treatment and prevent missed diagnoses.
Key Detection Focus	Unsuspected vertebral compression fractures (VCFs)	Incidental Pulmonary Embolism (iPE)
Processing Time	10-60 seconds	10-60 seconds

Videos

Demos, reviews, and walkthroughs featuring CINA-VCF and CINA-iPE.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the reported accuracy metrics, such as sensitivity and specificity, for CINA-VCF in detecting vertebral compression fractures, comparable to the detailed metrics provided for CINA-iPE?

CINA-VCF demonstrated a sensitivity of 95.2% and a specificity of 92.9% in a multicenter study involving 474 CT cases. This performance was consistent across various subgroups analyzed.

How do CINA-VCF and CINA-iPE integrate into a radiologist's existing PACS/RIS workflow to ensure seamless triage and notification of incidental findings without disrupting reading efficiency?

Both CINA-VCF and CINA-iPE are designed for seamless integration into standard reading environments like PACS and RIS. They operate in parallel to the ongoing standard of care image interpretation, automatically triggering and reporting algorithm results to prioritize suspected positive findings and send notifications without altering original images.

Considering the distinct clinical focus of each tool, for which specific patient populations or clinical pathways would CINA-VCF (VCFs) and CINA-iPE (PEs) offer the most significant diagnostic and treatment impact?

CINA-VCF is particularly impactful for adults aged 50 years and over undergoing chest and/or abdomen CT scans, aiming to prevent further bone density loss and fractures by addressing VCFs early, especially given that many go undetected. CINA-iPE is crucial for patients undergoing contrast-enhanced CT scans for other indications (not dedicated CTPA protocol) where incidental pulmonary embolisms are often missed, significantly benefiting oncology patients where iPE is a major cause of mortality.

What specific audit-trail functionalities do CINA-VCF and CINA-iPE provide to track the identification, notification, and subsequent radiologist review of critical findings?

While the provided information for CINA-VCF and CINA-iPE primarily mentions triage and notification software with worklist order output, implying a record of flagged cases, specific details on comprehensive audit-trail functionalities for tracking radiologist acknowledgment or review beyond initial notification are not explicitly detailed in the provided facts.

Beyond integration with PACS and RIS, what capabilities do CINA-VCF and CINA-iPE offer for deeper integration with electronic health record (EHR) systems to enrich patient context or streamline follow-up care?

The provided information primarily highlights integration with PACS and RIS for image processing and workflow prioritization. While the tools aim to improve patient outcomes and follow-up, deeper, explicit integration capabilities with broader EHR systems for comprehensive patient context or direct streamlining of follow-up care within the EHR are not detailed in the given facts.

Given the rapid processing times of 10-60 seconds for both tools, what is the expected learning curve for radiologists to become proficient, and how quickly can a practice expect to see clinical value?

Both CINA-VCF and CINA-iPE boast rapid processing times of 10-60 seconds, which contributes to quick time-to-value by enabling fast triage and notification. The tools are designed for seamless integration into existing workflows, suggesting a low learning curve for radiologists to incorporate them into their daily diagnostic routine and realize immediate benefits in terms of efficiency and earlier detection of critical incidental findings.